Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

By Ranuncolo Stella   Varela Mirta   Morandi Ana   Lastiri José   Christiansen Silvia   Bal de Kier Joffé Elisa   Pallotta María   Puricelli Lydia  

Journal of Neuro-Oncology, Vol. 68, Iss. 2, 2004-06 ,pp. : 113-121

Springer Publishing Company

Access to resources Recommend Favorite

The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses’ health studies

By Cox David   Deer Dwayne   Guo Qun   Tworoger Shelley   Hankinson Susan   Hunter David   Vivo Immaculata  

Cancer Causes and Control, Vol. 18, Iss. 6, 2007-08 ,pp. : 621-625

Springer Publishing Company

Access to resources Recommend Favorite

Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk

By Fu Qiang   Zhang Guoqiang   Chen Hongwei   Zheng Youwei   Cheng Jing  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3721-3729

Springer Publishing Company

Access to resources Recommend Favorite

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 569-576

Spandidos Publications

Access to resources Recommend Favorite

Possible prognostic significance of p53 immunoreactive status of hepatic colorectal cancer metastases following surgical resection

By Pocard M.   Paradis V.   Adam R.   Reynes M.   Bismuth H.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 594-595

Elsevier

Access to resources Recommend Favorite